ISMRC 2023 Final Programme

25 PS-03-004 p53-binding protein 1 accumulation in circulating tumor cells identifies che- motherapy-responsive metastatic breast cancer patients Kathrin Niedermayer, Germany PS-03-005 RAI2 controls polycomb-mediated re- pression of CDKN1A by its interaction with CtBP1 Sarah Greimeier, Germany PS-03-006 Identification of potential novel drivers and biomarkers of CDK4/6 inhibitor re- sistance in metastatic breast cancer Leonie Ott, Germany PS-03-008 Circulating tumour cell clusters in the metastatic development of prostate cancer Edwina Burke, United Kingdom Tuesday, 2 May 2023 – Poster Sessions Detecting residual cancer earlier and informing patient outcomes through the deployment of truly innovative liquid biopsy testing solutions. Cell3™ Preserver tubes : an easy-to-use direct-draw blood collection method that maintains white blood cell integrity for up to 15 days. Manual, spin column (Cell3™ Xtract) and bead-based automatable (Bead Xtract) extraction kits for all levels of throughput and lab set-up. Cell3™ Pan-Cancer Panel: Comprehensive mutation analysis across > 500 oncogenes. Cell3™ CustomMRD: Small, ultrasensitive, personalized panels for MRD monitoring.